Halaman 3 - Kanker nasofaring Dokter Terbaik - TOP-58 dokter

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Terlatih dalam onkologi radiasi di Universitas Marmara, berspesialisasi dalam teknik pengobatan kanker yang presisi.

• Spesialisasi dalam onkologi radiasi selesai pada tahun 2016
• Gelar medis dari Fakultas Kedokteran Universitas Marmara
• Praktik di Rumah Sakit Emsey

Associate Professor Dr. Emrah Eraslan spesialis dalam onkologi medis dengan fokus pada berbagai jenis kanker, termasuk kanker nasofaring, di Rumah Sakit Koru Ankara.

• Lebih dari 15 tahun pengalaman dalam penyakit dalam dan onkologi medis
• Menjalani pelatihan di Rumah Sakit Pendidikan dan Penelitian Onkologi Dr. Abdurrahman Yurtaslan Ankara
• Mempublikasikan berbagai makalah yang berkontribusi pada penelitian onkologi
• Spesialisasi dalam kanker payudara, prostat, paru-paru, dan kolorektal

Dr. Sridhar berspesialisasi dalam radioterapi untuk kanker nasofaring dengan pelatihan ekstensif dan keanggotaan profesional.

• Tersertifikasi dewan dalam radioterapi dengan pengalaman lebih dari 20 tahun
• Anggota Society for Neuro-Oncology dan Bangalore Oncology Group
• Menempuh pendidikan di Banaras Hindu University dan National Board Of Examination
• Aktif dalam Indian Association of Hyperthermia Oncology

Dr. Chaitainya Borde telah melakukan lebih dari 30.000 pemindaian PET dan merawat 1.000+ pasien kanker tiroid di HCG Manavata Cancer Centre.

• 12 tahun pengalaman kedokteran nuklir
• Keahlian dalam pemindaian PET-CT dan terapi radioiodine
• Penelitian yang dipublikasikan dalam jurnal medis
• Spesialisasi dalam layanan kardiologi nuklir

Dr. Shruti Kate berspesialisasi dalam kanker stadium lanjut, dengan keahlian dalam imunoterapi dan terapi metronomik. Beliau menempuh pendidikan di Tata Memorial Hospital, sebuah pusat kanker terkemuka.

• Berpengalaman dalam mengobati kanker paru-paru, payudara, und genitourinari
• Anggota ASCO, ESMO, dan komunitas onkologi bergengsi lainnya
• Mempresentasikan penelitian di Konferensi Dunia tentang Kanker Paru-paru
• Menerima penghargaan perjalanan atas kontribusinya di bidang onkologi

Dr. Shaunak mempresentasikan penelitian terobosan tentang Kanker Lambung di Simposium American Society of Clinical Oncology di San Francisco.

• Menjalani pelatihan Onkologi Medis di Rumah Sakit Indraprastha Apollo, New Delhi
• Berdireksi pada terapi target berdasarkan penelitian kanker molekuler
• Memberikan kuliah di International Winter School of Oncology di AIIMS
• Berpengalaman sebagai Registrar Onkologi Medis di Rumah Sakit Kanker Jawaharlal Nehru

Dr. Raj Nagarkar telah melakukan lebih dari 50.000 operasi kanker selama 19 tahun, dengan spesialisasi dalam Onkologi Bedah Payudara dan Toraks di HCG Manavata Cancer Centre.

• Terlatih di Tata Memorial Hospital dan Royal College of Surgeons, Edinburgh
• Terlibat dalam lebih dari 200 uji klinis, termasuk studi fase 1-3
• Profesor untuk DNB Superspecialty Bedah Onkologi dan Bedah Payudara
• Fokus pada peningkatan kualitas hidup pasien pasca-perawatan